Overcoming Challenges in Antibacterial Drug Discovery and Development

Produk Detail:
  • Author : Aarti Raja
  • Publisher : Unknown
  • Pages : pages
  • ISBN :
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Overcoming Challenges in Antibacterial Drug Discovery and Development

Download or Read online Overcoming Challenges in Antibacterial Drug Discovery and Development full in PDF, ePub and kindle. this book written by Aarti Raja and published by Unknown which was released on 13 June 2021 with total page pages. We cannot guarantee that Overcoming Challenges in Antibacterial Drug Discovery and Development book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like.

Artificial Intelligence in Oncology Drug Discovery and Development

Artificial Intelligence in Oncology Drug Discovery and Development
  • Author : John Cassidy,Belle Taylor
  • Publisher : BoD – Books on Demand
  • Release : 09 September 2020
GET THIS BOOK Artificial Intelligence in Oncology Drug Discovery and Development

There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development

Protein Kinases in Drug Discovery

Protein Kinases in Drug Discovery
  • Author : Rossen Donev
  • Publisher : Academic Press
  • Release : 01 March 2021
GET THIS BOOK Protein Kinases in Drug Discovery

Protein Kinases in Drug Discovery, Volume 124 discusses the latest information on protein kinases and how they modify other proteins by chemically adding phosphate groups to them. New chapters in this release include Transport Proteins and AMPs: Implications in Human Disease, Protein kinase CK2 inhibition as a pharmacological strategy, Emerging role of Protein kinase in diabetes mellitus: From Mechanism to therapy, Dual Roles of ATP-binding site in Protein Kinases: Orthosteric inhibition and Allosteric Regulation, Pseudokinases in drug discovery and development: progress,

Oral Formulation Roadmap from Early Drug Discovery to Development

Oral Formulation Roadmap from Early Drug Discovery to Development
  • Author : Elizabeth Kwong
  • Publisher : John Wiley & Sons
  • Release : 06 February 2017
GET THIS BOOK Oral Formulation Roadmap from Early Drug Discovery to Development

Detailing formulation approaches by stage of discovery to early development, this book gives a “playbook” of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development. • Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry • Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research • Features case studies to illustrate practical challenges and solutions in formulation selection •

Frontiers in Anti Infective Drug Discovery Volume 8

Frontiers in Anti Infective Drug Discovery  Volume 8
  • Author : Atta-ur-Rahman,Muhammad Iqbal Choudhary
  • Publisher : Bentham Science Publishers
  • Release : 05 October 2020
GET THIS BOOK Frontiers in Anti Infective Drug Discovery Volume 8

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials

Drug Discovery and Development Third Edition

Drug Discovery and Development  Third Edition
  • Author : James J. O'Donnell,John Somberg,Vincent Idemyor,James T. O'Donnell
  • Publisher : CRC Press
  • Release : 21 November 2019
GET THIS BOOK Drug Discovery and Development Third Edition

Drug Discovery and Development, Third Edition presents up-to-date scientific information for maximizing the ability of a multidisciplinary research team to discover and bring new drugs to the marketplace. It explores many scientific advances in new drug discovery and development for areas such as screening technologies, biotechnology approaches, and evaluation of efficacy and safety of drug candidates through preclinical testing. This book also greatly expands the focus on the clinical pharmacology, regulatory, and business aspects of bringing new drugs to the

Burger s Medicinal Chemistry and Drug Discovery Therapeutic Agents

Burger s Medicinal Chemistry and Drug Discovery  Therapeutic Agents
  • Author : Manfred E. Wolff
  • Publisher : Wiley-Interscience
  • Release : 26 April 1996
GET THIS BOOK Burger s Medicinal Chemistry and Drug Discovery Therapeutic Agents

The most comprehensive source of the latest information in drug discovery and medicinal chemistry BURGER'S MEDICINAL CHEMISTRY AND DRUG DISCOVERY, FIFTH EDITION, Volume 2: Therapeutic Agents Renowned for its incisive, systematic examination of the new classes of drugs, Burger's Medicinal Chemistry and Drug Discovery provides professionals with thorough, yet selective access to drug chemistry information in a convenient format. Volume 2 outlines the newest generation of drugs with the potential for controlling cardiovascular, gastrointestinal, and tubercular disease. These include: * Cholinergics and anticholinergics *

Peptide based Drug Discovery

Peptide based Drug Discovery
  • Author : Ved Srivastava
  • Publisher : Royal Society of Chemistry
  • Release : 26 June 2017
GET THIS BOOK Peptide based Drug Discovery

With potentially high specificity and low toxicity, biologicals offer promising alternatives to small-molecule drugs. Peptide therapeutics have again become the focus of innovative drug development efforts backed up by a resurgence of venture funds and small biotechnology companies. What does it take to develop a peptide-based medicine? What are the key challenges and how are they overcome? What are emerging therapeutics for peptide modalities? This book answers these questions with a holistic story from molecules to medicine, combining the themes

Natural Products

Natural Products
  • Author : Lixin Zhang,Arnold L. Demain
  • Publisher : Springer Science & Business Media
  • Release : 17 November 2007
GET THIS BOOK Natural Products

A fresh examination of the past successes of natural products as medicines and their new future from both conventional and new technologies. High-performance liquid chromatography profiling, combinatorial synthesis, genomics, proteomics, DNA shuffling, bioinformatics, and genetic manipulation all now make it possible to rapidly evaluate the activities of extracts as well as purified components derived from microbes, plants, and marine organisms. The authors apply these methods to new natural product drug discoveries, to microbial diversity, to specific groups of products (Chinese

Nanostructured Biomaterials for Overcoming Biological Barriers

Nanostructured Biomaterials for Overcoming Biological Barriers
  • Author : Maria Jose Alonso,Noemi S. Csaba
  • Publisher : Royal Society of Chemistry
  • Release : 30 June 2012
GET THIS BOOK Nanostructured Biomaterials for Overcoming Biological Barriers

This book provides a critical overview of the advances being made towards overcoming biological barriers through the contribution of nanosciences and nanotechnologies. Overcoming these barriers is of primary importance for solving the problems of many current drugs and vaccines and it is also especially relevant for the commercial exploitation of new therapeutic strategies i.e. gene and cellular therapies. Despite important information that has been covered in recently published books related to nanomedicine (mainly oriented to technologies and applications), there